Real-time Stock quotes, portfolio, LIVE TV and more.
Aug 02, 2012, 07.32 PM IST
Gilead Sciences Inc signed deals with three Indian companies to drive sales and reduce manufacturing costs of low-cost generic versions of its HIV drug, Emtricitabine in developing countries.
Gilead, which sells the drug under the Emtriva brand, is the world's largest maker of branded drugs to treat the human immunodeficiency virus -- the cause of AIDS.
Tags: Gilead Sciences Inc , deals, Emtricitabine , three Indian companies , Ranbaxy Laboratories, Strides Arcolab , Mylan Inc
Action in Ranbaxy Laboratories
May 23 2013, 16:33
- in Asian markets
May 23 2013, 09:33
- in Technicals